These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3980329)

  • 1. Influence of ampicillin elimination half-life on in-vitro bactericidal effect.
    White CA; Toothaker RD
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():257-60. PubMed ID: 3980329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coli.
    White CA; Toothaker RD; Smith AL; Slattery JT
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1046-51. PubMed ID: 2675754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial kinetics of ampicillin against Escherichia coli under simulated in vivo conditions.
    Fuglesang JE; Bergan T
    Infection; 1982 Jan; 10(1):31-4. PubMed ID: 7040252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the growth dynamics of multiple Escherichia coli strains in the pig intestine following intramuscular ampicillin treatment.
    Ahmad A; Zachariasen C; Christiansen LE; Græsbøll K; Toft N; Matthews L; Nielsen SS; Olsen JE
    BMC Microbiol; 2016 Sep; 16(1):205. PubMed ID: 27599570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiological relevance and clinical potential of ampicillin-cloxacillin synergism.
    Barrelet L; Regamey C; Waldvogel FA
    Biomedicine; 1977 May; 26(3):169-75. PubMed ID: 329905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal activity of ampicillin and amoxicillin.
    Shah PM
    J Antimicrob Chemother; 1981 Nov; 8 Suppl C():93-9. PubMed ID: 6798012
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of amoxycillin--a new semisynthetic penicillin.
    Sabto J; Carson P; Morgan T
    Med J Aust; 1973 Sep; 2(11):537-41. PubMed ID: 4748581
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative in-vitro antibacterial activity of two brands of antibiotics against clinical isolates of some bacterial genera.
    Odelola HA; Jaiyebo O; Anukam PA; Akanni AO
    Afr J Med Med Sci; 1989 Dec; 18(4):307-10. PubMed ID: 2558563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bactericidal activity of serum and chemotherapy in sensitive and resistant exciter (author's transl)].
    Eyer H; Metz H; Preac-Mursic V
    Med Klin; 1975 Nov; 70(47):1915-9. PubMed ID: 765704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New semisynthetic penicillin: amoxicillin. In vitro experiences and evaluation of the absorption. Comparison with ampicillin].
    Lodola E; Marca G
    G Ital Chemioter; 1973; 20(1-4):27-35. PubMed ID: 4806387
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative activities of ampicillin, epicillin and amoxycillin in vitro and in vivo.
    Basker MJ; Gwynn MN; White AR
    Chemotherapy; 1979; 25(3):170-80. PubMed ID: 256524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antimicrobial activities of ribostamycin, gentamicin, ampicillin and lincomycin in vitro and in vivo.
    Inouye S; Watanabe T; Kitasato I
    Drugs Exp Clin Res; 1989; 15(10):465-76. PubMed ID: 2632215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New ampicillin derivatives with glyoxyloylbenzhydrazone side chains].
    Heinisch L; Hanschke KG; Willitzer H; Möllmann U; Tresselt D; Stengel K; Eckardt K; Kleinwächter W
    Pharmazie; 1992 Jun; 47(6):412-5. PubMed ID: 1409839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergy of ampicillin and chloramphenicol against gram-negative bacteria.
    Kaplan SL; Mason EO
    Pediatr Pharmacol (New York); 1981; 1(4):305-11. PubMed ID: 7346749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].
    Duez JM; Péchinot A; Siébor E; Cordin X; Kazmierczak A
    Pathol Biol (Paris); 1989 Apr; 37(4):263-8. PubMed ID: 2543946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of seven common pathogenic bacteria to doxycycline (vibramycin), tetracycline HCI and ampicillin in vitro.
    Hill A
    Med J Aust; 1972 Dec; 2(23):1295-6. PubMed ID: 4567797
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibacterial activity of the combination ampicillin-kanamycin against gram-negative bacteria.
    Klastersky J; Daneau D; Van Moer N
    Pathol Biol (Paris); 1972 May; 20(9):443-8. PubMed ID: 4625078
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of subminimal inhibitory concentrations of ampicillin on hemagglutination of Escherichia coli.
    Nishimoto K; Maruyama S; Yasukawa A; Ozaki M
    Hiroshima J Med Sci; 1992 Mar; 41(1):13-7. PubMed ID: 1349303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
    Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
    Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM; Mackay E; Marks MI
    Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.